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Maternal outcome in eclampsia at Harare Maternity Hospital
F MAJOKO, C MUJAJI
Abstract
Objectives: To study the presentation, management and determinants of maternal outcome in eclampsia at 
Harare Maternity Hospital (HMH) in order to design interventions for reduction of maternal mortality. 
Design: Cross sectional descriptive study.
Setting: Harare Maternity Hospital, Harare, Zimbabwe
Subjects:All women with diagnosis of eclampsia treated at HMH during an 18 month period.
Main Outcome Measures: The study variables included age, parity, booking status, gestational age, location 
at time of first seizure, number of fits, seizure to delivery interval, maternal complications and the clinical 
management.
Results: There were 151 women with eclampsia from 25 425 deliveries in HMH (5.9 per 1 000 deliveries). 
The case fatality was 26.5%. The majority of fits (67.5%) occurred antepartum. The mothers who died were 
significantly older than the survivors, mean age 25.8 versus 22.3 (p=0.007), and had a higher proportion of 
multiple seizures, 0.67 versus 0.39 (p=0.009). In 38% of cases the first seizure occurred at home. The 
proportion of complications was higher among those who died. Deficiencies in clinical management were 
more common in the women who died, 39.5% versus 20.9% for survivors (OR 2.55; 95% Cl 1.09 to 5.99) and 
they included delays in achieving delivery, inadequate clinical assessment and poor monitoring. 
Conclusion: Eclampsia remains a significant cause of maternal mortality in HMH with a high case fatality 
rate. Advanced maternal age, antepartum onset of convulsions and multiple fits were associated with 
increased risk of maternal death. There wer&deficiencies in the clinical management of a high proportion of 
cases. r
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Introduction
Sub-Saharan Africa has one of the world’s highest maternal 
mortality ratios, estimated at 870/100 000 live births.1 
Maternal mortality for the Greater Harare Maternity Unit 
(GHMU) was 370/100 000 live births in 1997 and eclampsia 
was responsible for 24.2% of maternal deaths.2 In the 
Greater Harare Maternity Unit (GHMU) the proportion of 
maternal deaths due to eclampsia has ranged between eight 
and 24% (Figure I).
The proportion of maternal deaths due to eclampsia in 
similar settings ranges between 14 and 39%.3,4 Case fatality 
for eclampsia varies widely.3:5'9 There is need to reduce 
maternal mortality and interventions to achieve this 
reduction need to identify preventable causes of maternal 
death. Eclampsia is one such cause where case fatality can 
be reduced.
We conducted a contemporaneous review of all clinical 
notes of women with a diagnosis of eclampsia managed in 
HMH from January 1997 to June 1998 with the purpose of
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Figure I: Contribution of eclampsia to maternal mortality in the GHMU, 1983 to 1997.
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identifying factors which adversely affected maternal 
outcome. Identification of risk factors for maternal death 
in eclamptic women was an essential step in the process of 
designing intervention strategies for reduction of maternal 
deaths from this preventable cause.
Materials and Methods
This was a cross sectional study of women with eclampsia 
in a tertiary hospital of a developing country. The GHMU 
is made up of a tertiary referral centre, HMH and 13 
midwife-run municipal clinics that offer first level obstetric 
services. Apart from patients referred from the midwife- 
run urban clinics, HMH acts as a referral centre for all 
district and provincial hospitals in the northern half of 
Zimbabwe. All patients with eclampsia in the GHMU were 
referred to HMH. Patients with a diagnosis of eclampsia 
were admitted to a high care area located on the labour 
ward. Guidelines for the management of eclampsia in the 
. hospital include:
1. Control of convulsions by an intravenous bolus of 
diazepam 10 mg.
2. Prevention of further fits by either the magnesium 
sulphate regime as described by Crowther 10 or an 
intravenous infusion of diazepam 80mg in one litre of 
5% dextrose.
3. Control of hypertension by boluses of dihydrallazine 
to maintain diastolic blood pressure below 110mm 
Hg.
4. Delivery by the quickest safe route.
All women admitted wj.th a diagnosis of eclampsia and 
those who developed eclarrfpsia after admission to HMH
were included in the analysis. A register was kept on the 
labour ward in which cases of eclampsia were recorded. 
The cases were identified daily by CM and all the clinical 
notes were reviewed by FM.
Epi Info 6 was used for data handlihg. Women who 
survived eclampsia were considered referents and those 
who died were the cases. Risks were analysed as odds ratio 
(OR) with 95% confidence intervals (Cl) and p value <0.05 
was considered significant. The study variables included 
age, parity, booking status, gestational age, timing of 
seizure, location at first seizure, number of fits, seizure to 
delivery interval, admission to the intensive care unit 
(ICU), complications and maternal outcome. An assessment 
.of the clinical management of the woman was made 
without blinding for maternal outcome. Avoidable factors 
were identified and were assigned a level of avoidability
i.e. patient factors, factors at referring unit and those at the 
central unit.
Results
There were 151 women with a diagnosis of eclampsia 
attended to during the 18 month period, 37 (24.5%) of 
whom experienced the first convulsion after admission, to 
HMH. There were 25 425 deliveries in the hospitalduring 
this period and the incidence of eclampsia at HMH was 
therefore 5.9/1000 deliveries. Ninety one women (60.3%) 
with eclampsia were referred from outside the GHMU. 
The GHMU, however, had 56 500 deliveries in the same 
period. There were 40 deaths among the eclamptic women 
thus giving a case fatality of 26.5%.
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Table I: Age distribution (%) of eclampsia patients 
compared to the general GHMUpatients.
A g e  g ro u p E c la m p s ia G H M U  o b s te t r ic s  p o p u la t io n
s 1 5 2 .6 1 .0
1 6 -1 9 33 .1 2 0 .3
2 5 -2 9 1 6 .6 2 2 .9
3 0 -3 4 7 .9 10 .2
a 3 5 7 .9 7 .7
The age distribution of the women with eclampsia and of 
the general obstetric population are as shown in Table I. 
There was no difference in mean age between the women 
with eclampsia and the general obstetric population, 23.2 
(S.D. 6.2) and 24.4 (S.D. 5.9) years respectively.
The median parity and inter-quartile range for the unit 
was one (0; 2) and that for the women with eclampsia was 
zero (0; 1).
The women with eclampsia were, therefore, similar to 
the general obstetric population served by Harare Maternity 
Hospital in terms of age and parity.
The mortality for eclampsia increased with maternal age 
and the Chi-square test for trend was 7.295, p=0.006. 
Figure II shows the trend of increasing maternal mortality 
with maternal age.
The women who died were significantly older, mean age 
25.8 versus 22.3 (p=0.007) and of higher parity, median 
one (0; 2) versus zero (0;1) (p=0.02) than those who 
survived. There was a high rate (28.4%) of unbooked 
mothers among the women who developed eclampsia. The 
rate of unbooked women for the unit during this period was 
14%.11 There was no difference in mean gestational age at 
onset of eclampsia for the women who survived and those 
who died; 34.8 (S.D.4.6) and 33.8 (S.D.5.0) weeks 
respectively.
Table II: Effect o f demographic factors on maternal 
outcome. Odds ratio (OR) with 95% confidence intervals 
(Cl) using survivors as referents or p value.
C h a ra c te r is t ic S u rv iv o rs D e a d O R (9 5 % C I) o r  p  v a lu e
M e a n  a g e (S D ) 2 2 .3 (5 .6 ) 2 5 .8 (7 .3 ) p = 0 .0 0 6
M ed ian  parity (q1 ;q3) 0 (0 ;1 ) 1 (° ;2 ) p = 0 .0 2
G e s ta t io n  a g e  (w e e k )
2 3 7 11 1
< 2 1 4 4 4 .0 9  (0 .6 4 -2 5 .2 )
2 8 -3 6 45 20 1 .8 2  (0 .7 3 -4 .6 1 )
N o t sta ted 17 5
B ooked 79 3 0 1
U nbooked 3 2 10 0 .8 2  (0 .3 3 -2 .0 1 )
T im in g  o f  c o n v u ls io n  (% )
A n tep artu m 69 3 5 4 .8 2  (1 .0 5 -4 4 .6 )
In trapartum 19 2 1
P o stpartum 23 3 1 .2 4 (0 .1 3 -1 6 .2 )
L o c a tio n  a t  f i r s t  s e iz u re  (% )
H M H 27 10 1
H o m e 49 17 0 .9 4  (0 .3 4 -2 .5 7 )
Lofcal clinic/ 3 5 13 1 .0 0 (0 .3 4 -2 .9 3 )
'SD Standard deviation.
The majority of seizures, 102 (67.5%), occurred 
antepartum and mortality was higher for women who 
developed antepartum eclampsia, (OR 4.82; 95%CI 1.05 
to 44.60).
In 57 women (38.3%) the first convulsion occurred at 
home. There was no difference in maternal outcome for 
women who experienced the first convulsion at home 
compared to those whose first convulsion was in HMH 
(OR 0.94; 95% Cl 0.34 to 2.57).
Figure II: Relationship betwen maternal age and mortality.
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Table 111: Effect of the severity of clinical condition on 
mortality. Odds ratio with 95% confidence intervals (Cl) 
using survivors as referents.
F a c to r S urvivors Dead O R  (95%  Cl)
T o ta l num b er o f co nvu ls ions
1 3 6 7 T
2 14 3 1 .1 0  (0 .1 9 -5 .8 1 )
2 3 2 4 13 4.11 (1 .0 3 -1 7 .0 )
U nkno w n 3 7 17
M ean blood  p ressure (S D )
S y s to lic , 1 6 6 (3 1 ) 1 7 3 (2 9 ) p = 0 .3 7 9
Diasto lic 1 0 9  (1 9 ) 1 1 8 (1 9 ) ■ p = 0 .1 7 0
C om plica tions
No 93 14 1
Y e s 18 2 6 9 .6 0  (3 .9 2 -2 3 .9 )
N um ber o f co m p lica tio n s
N o n e 9 3 14 1
1 18 2 6 9 .6 0  (3 .9 2 -2 3 .9 )
2 2 3 9 1 9 .9  (4 .1 5 -1 5 - .
1 2 2 .9 )
ICU adm iss ion
No 9 8 2 5 1
Y e s 13 15 4 .5 2  (1 .7 6 -1 1 .7 )
C om plica tions  in IC U  p a tien ts
D IC  (n =8) 0 5
T h ro m b o cyto p en ia  (n = 1 6 ) 3 5
R en a l fa ilu re  (n = 9 ) 1 6 .
C V A (n -6 ) 0 5
*SD Standard deviation.
*ICU Intensive care unit.
*DIC Disseminated intravascular coagulation.
*CVA Cerebrovascular accident.
Women who had more than two seizures had poor 
maternal outcome, (OR 4.11; 95% Cl 1.03 tol7.0). Although 
the blood pressure was marginally higher in the women 
who died, the difference was not significant. Complications 
were recorded more frequently in the women who died, 
26/40 versus 18/111 (p<0.001). The complications included 
dissem inated intravascular coagulation (DIC), 
thrombocytopenia, renal failure and cerebro-vascular 
accident. There was a direct relationship between number 
of complications and maternal outcome.
Glasgow coma scale rating was performed by one 
observer in 14 women. There was no correlation between 
the level of consciousness and maternal outcome.
Only 28 women (19%) were admitted to the intensive 
care unit (ICU). A higher proportion of women who later 
died had been admitted to ICU, 42.4% versus 11.9% 
(p < 0.001) for dead and survivors respectively.
Nine women (6.0%) died before delivery. The overall 
Caesarean section rate was 63.0%. Among women with 
antepartum eclampsia, the Caesarean section rate was 
81.7%. There was a significant difference in Caesarean 
section rates among the women who survived (89.7%) and 
those who died (60%) (OR 0.15; 95% Cl 0.02 to 0.82), The 
perinatal mortality rate in women who suffered antepartum
Table TV: Assessment of clinical management; odds ratio 
and 95% Cl with survivors as referents.
C haracteris tic S urv ivors Dead O R  (95% C I)
M ode of de livery  in w o m en  w ith  antenatal fits
S p o n tan e o u s vag in a l 2 4 1
-A ssisted vag ina l 5 6 . 0 .7 2  (0 .0 8 -6 .6 6 )
C a e s a re a n  section 61 15 0 .1 5  (0 .0 2 -0 .8 2 )
C onvu ls ion  to  d e live ry  in terval
s 6 2 2 5 1
6 -1 2 3 4 ' 6 0 .7 8  (0 .1 8 -3 .4 1 )
2 1 2 16 6 1 .65  ( 0 .3 6 -7 .7 9 )
U nkno w n 16 18
A ssessm en t o f c lin ica l m anagem ent
Satisfactory 88 25 1
U nsatisfactory 23 15 2 .5 5  (1 .0 9 -5 .9 9 ) '
In ad eq u ate  m onitoring  
4 .4 8 .8 )
•3 8 9 .3 9  (2 .0 4 -
D e la y e d  delivery 20 7 1 :2 3  (0 .4 2 -3 .5 4 )
seizures was 146/1 000, which was much higher than the 
53/1000 for the GHMU.
The mean seizure to delivery interval was 11.1 (S.D. 9.0) 
and 13.2 (S.D. 13.1) hours for the women who survived 
and those-who died respectively. There appeared to be no 
association between seizure to delivery interval and 
maternal outcome. The time of onset of convulsions was 
not recorded in some women, especially those with onset 
of eclampsia at home.
. Diazepam was the most frequently used anticonvulsant. 
Magnesium sulphate was used in combination with 
diazepam in 39 patients (26%). There were no cases where 
magnesium sulphate was used as a single agent for the 
control and prevention of fits.
Delay in achieving a delivery occurred frequently, 18% 
in both groups, but inadequate monitoring was a common 
finding in the women who died. Delay in delivery for the 
hospital was defined as an interval longer than six hours 
after the decision to deliver had been taken.
Cerebral hypoxia and cerebro-vascular accident (CVA) 
were the most frequent causes of death accounting for 19 
(55.9%) and 10 (29.4%) respectively.
Discussion
Eclampsia remains an important cause of maternal mortality 
in many developing country settings.3’4'6'7'10'12 We found 
advanced maternal age, antepartum onset of seizures and 
multiple seizures to be risk factors for maternal death in 
eclamptic women. The development of complications and 
deficiencies in clinical management also contributed to 
maternal mortality.
In a tertiary unit with women referred after onset of 
convulsions from an unknown source population, the rate 
of eclampsia is difficult to compute. We used the HMH 
deliveries and all women with diagnosis of eclampsia, 
regardless of location at onset of convulsions, to calculate
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the rate of eclampsia for HMH. An alternative, and probably 
more accurate reflection of the incidence, would have been 
to consider only women whose first convulsion occurred 
after admission to HMH which would give an incidence of 
1.46/1 000 deliveries. Similar problems in calculating 
rates for tertiary institutions with no defined source 
population have been alluded to previously.4'7'13 The rate of 
eclampsia in our hospital of 5.9/1 000 was similar to rates 
from other developing country settings3,4'7'8 but lower than 
the 77/1 000 deliveries reported from Turkey.9 An earlier 
report from our institution gave an eclampsia rate of 0.6/1 
000 deliveries.13 The difference in incidence rates over the 
two periods may suggest an increase in the incidence of 
eclampsia as has been observed from other centres within 
the sub-region.7 The incidence of eclampsia in our setting 
is much higher than the rates reported from Europe and 
North America.5,14'15
Our finding of high maternal complications and mortality 
associated with antenatal onset of convulsions is in 
agreement with previous reports.5'13 Of concern is the very 
high case fatality rate, 26.5% for eclampsia in GHMU. The 
case fatality, for women who experienced their first 
convulsion in the tertiary hospital was no better, 23.4%. 
Crowther16 reported a case fatality of 4% for women 
booked in the same unit. A high case fatality for eclampsia 
(21.2%) has also been reported from a similar setting in 
South Africa.4 Most reports in similar settings report case 
fatality rates between 2.9 and 9.5%3,6'8,12while case fatality 
is as low as 0.4% in the western world.15
It is'generally assumed that women who convulse for the 
first time within a health institution have a better 
outcome3'9 but this was not true for our setting. There was 
no difference in outcome among mothers who convulsed at 
home and those who did so after admission to the tertiary 
unit. This unexpected finding may be a reflection of the 
ciinical management in the hospital. A high proportion 
(84/151) of patients suffered their first convulsion while 
under medical supervision, either at the local (n=47) or 
central unit (n=37). High rates of women suffering their 
first convulsion in hospital have been reported 
previously.5'13,15 The fact that a high proportion of patients 
convulsed after admission raises the question of how 
preventable eclampsia is. In the series reported by Sibai15 
13% of cases experienced their first convulsion while they 
were on the standard magnesium sulphate regime for pre­
eclampsia. Abi-Said et al17 recommended the use of 
magnesium sulphate for prevention of eclampsia although 
they acknowledged the occurrence of fits even in patients 
already on the recommended treatment. Odendaal18 
questions the value of magnesium sulphate as a prophylactic 
agent in severe pre-eclampsia. It is hoped that the Magpie 
trial19 will answer the question of the use of magnesium 
sulphate in severe pre-eclampsia for prevention of 
eclampsia.
There was a high rate of unbooked women in both groups 
(28%). High rates of unbooked patients among women 
witheclampsiahave been reported previously.3,4'6,8’12 Several
reports4,12'13 have shown a lower case fatality among booked 
women. There is a suggestion that prenatal care could have 
played a role in the reduction of eclampsia in the developed 
world14 but there is no convincing evidence to support this 
view especially considering the number of booked patients 
who develop eclampsia under medical supervision. In a 
proportion of women, there may be no warning signs of the 
impending eclampsia6-9 as up to 85% of women have 
normal antenatal findings within seven days of onset of 
eclampsia4,5'13 and where such signs exist the medical 
attendants often fail to take appropriate action.
The number of convulsions had a direct relationship to 
maternal outcome, with the mortality rising with the number 
of fits. This finding is in agreement with previous 
observations.3'4,9'20 An effective anti-convulsant that 
prevents further seizures has an important role in the 
management of women with eclampsia and magnesium 
sulphate has been shown to be the best agent.21 Despite 
having participated in two trials on the use of magnesium 
sulphate in eclampsia,10,21 the GHMU has been using this 
drug in an erratic fashion, partly due to drug non-availability 
at times. Only 26% of the patients in this series received 
magnesium sulphate.
Eclampsia is generally a disease of the first pregnancy, 
54.7% of this group were primigravidae. This rate is 
comparable to reports from similar settings.3'4,6'8'12 These 
were young women with a mean age of 23.2 years (S.D. 
6.2) and therefore a mortality rate of 20% is unacceptably 
high.
There was a high Caesarean section rate (63 %) in women 
with eclampsia compared to the GHMU rate of 15 %. Mode 
of delivery did not appear to have any influence on maternal 
outcome. There is need to review the indications for 
Caesarean section in this group of women, as some of them 
could be induced and deliver vaginally. High Caesarean 
section delivery has been reported previously.4,7'91213 We 
could not find a protective effect of Caesarean section 
against maternal mortality as reported by others.3,22 There 
have been suggestions that a large proportion of women 
with eclampsia could benefit from induction of labour and 
a vaginal delivery20 but only 18.3% (19/104) of women 
with antepartum onset of convulsion were delivered 
vaginally.
An unexpected result was the lack of association between 
maternal outcome and the interval between onset of seizures 
and delivery. The median onset of eclampsia to delivery 
interval was longer than reported by Crowther16 from the 
same unit. The longer interval to delivery again may be a 
reflection on the declining quality of care associated with 
the high case fatality rate. Previous reports3,9 suggested 
that maternal outcome deteriorated with prolongation of 
the interval between the onset of seizures and delivery. 
Breen20 recommends a four hour interval for stabilisation 
of the patient prior to delivery, during which time attempts 
are made to ensure a vaginal delivery by use of misoprostol 
for induction of labour.
Eclampsia is a multi-organ disease associated with a 
wide range of complications. Complications occurred more
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frequently among the women who died and the risk of 
mortality increased with multiple complications. High 
rates of complications in women with eclampsia appear to 
occurfrequently.fj'9J2There were deficiencies intheclinical 
management in both groups of women, but the proportion 
of women with sub-optimal clinical management was 
higher in the women who died (21%). Poor clinical 
judgement and delay in delivery were the most common 
clinical deficiencies. Crowther16 reported poor monitoring 
in up to 50% of eclamptic women in the same unit. Sub­
standard care has also been identified as a contributor to the 
high maternal mortality in other settings.4,7 The case 
fatality could be reduced by improving clinical 
management.
The major causes of death were cerebral hypoxia related 
to the seizures and cerebro-vascular accidents (intra­
cerebral haemorrhage).
The main limitations of the inquiry were the missing 
information from the clinical records especially for women 
referred from outside the Unit and the bias due to non­
blinding for maternal outcome. The tendency was to be 
more critical in cases of maternal death.
Potential for Reducing Case Fatality.
The case fatality rate for eclampsia over the 18 month • 
period was unacceptably high and was associated with 
deficiencies of care at all levels. The protocol for the 
management of eclampsia should be adhered to and the 
supply of an effective anti-convulsant (magnesium 
sulphate) needs to be improved. There is need.for co­
operation with anaesthetists and physicians in the 
management of eclampsia as there is a high frequency of 
complications in these patients. Despite the more frequent 
complications, monitoring was poor in the women who 
died. There is a need, therefore, to improve and strengthen 
the provision of emergency obstetric care.
Conclusion
Older women with multiple convulsions, especially those 
that commence antepartum are more likely to die from 
eclampsia. The case fatality for eclampsia was high and 
there is scope for reduction as avoidable factors were 
identified in a high proportion of cases. The clinical 
management in cases of eclampsia needs to be more 
aggressive if mortality is to be reduced.
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